Search research articles
Contact Us
Filters
Showing results (881-890 of 896) with videos related to
Page
of 90
Sort By:
Research and Practice in Thrombosis and Haemostasis
|
August 22, 2022
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin
Ingrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf, et al.
Cancer Discovery
|
May 1, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
Rona Yaeger, Meredith A McKean, Rizwan Haq, et al.
The New England Journal of Medicine
|
April 13, 2026
Endovascular Therapy for Post-Thrombotic Syndrome - A Randomized Trial
Suresh Vedantham, Susan R Kahn, William A Marston, et al.
Blood Advances
|
June 24, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
Adam Cuker, Eric K Tseng, Holger J Schünemann, et al.
Nature Chemical Biology
|
October 29, 2013
Niche-based screening identifies small-molecule inhibitors of leukemia stem cells
Kimberly A Hartwell, Peter G Miller, Siddhartha Mukherjee, et al.
Nature Genetics
|
August 2, 2001
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
J Magré, M Delépine, E Khallouf, et al.
Blood Advances
|
February 9, 2021
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances
|
September 2, 2021
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances
|
May 3, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
JACC. Advances
|
June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19
Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
Page
of 90
Search research articles
Search
Showing results (881-890 of 896) with videos related to
Sort By:
Page
of 90
Research and Practice in Thrombosis and Haemostasis
|
August 22, 2022
Postthrombotic syndrome and quality of life after deep vein thrombosis in patients treated with edoxaban versus warfarin
Ingrid M Bistervels, Roisin Bavalia, Jan Beyer-Westendorf, et al.
Cancer Discovery
|
May 1, 2024
A Next-Generation BRAF Inhibitor Overcomes Resistance to BRAF Inhibition in Patients with BRAF-Mutant Cancers Using Pharmacokinetics-Informed Dose Escalation
Rona Yaeger, Meredith A McKean, Rizwan Haq, et al.
The New England Journal of Medicine
|
April 13, 2026
Endovascular Therapy for Post-Thrombotic Syndrome - A Randomized Trial
Suresh Vedantham, Susan R Kahn, William A Marston, et al.
Blood Advances
|
June 24, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients
Adam Cuker, Eric K Tseng, Holger J Schünemann, et al.
Nature Chemical Biology
|
October 29, 2013
Niche-based screening identifies small-molecule inhibitors of leukemia stem cells
Kimberly A Hartwell, Peter G Miller, Siddhartha Mukherjee, et al.
Nature Genetics
|
August 2, 2001
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
J Magré, M Delépine, E Khallouf, et al.
Blood Advances
|
February 9, 2021
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances
|
September 2, 2021
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
Blood Advances
|
May 3, 2022
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Adam Cuker, Eric K Tseng, Robby Nieuwlaat, et al.
JACC. Advances
|
June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19
Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
Page
of 90